Treatment Guideline: Use of Bone-Modifying Agents in Patients with Breast Cancer
The Breast Oncology Center at Dana-Farber Cancer Institute held multidisciplinary meetings in October 2022 and February 2023 to discuss recommendations for bone-modifying agents in patients with breast cancer.